The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Me either trills, when I heard that the UK government granted legal immunity to Pfizer against law suits for adverse effects it put me right off. It does look like the UK is jumping in quicker than Europe.
Having spoke to a fella who’s friend works for GSK, developing drugs for COVID currently, including a vaccine. He reckons 2022 before we are back to pre covid lives. Vaccine roll out will be very very challenging and the first few months of 2021 won't be any different than now. Government will spin you yarns with promises and keep us bobbing along in and out of lockdowns and tiers until summer.
Must be a few boys on the sauce today.... What will be will be, although I’m still under water I’m happy to sit back and let the story unfold. 1 billion MCap before DVRG gets bought out in 3-5 years time by a big pharma. AI and data is where its at.
RB40 beat me to it with a much more comprehensive answer :-)
Cinders15 it does help to read the RNS’s once in a while!
It’s still in phase 3 testing, results expected early 2021.
one thing to remember is it’s not just a COVID breathalyser it’s can be used to identify many different pathogens and other diseases by changing the surface of the chip to match the spike protein of whatever pathogens you wish to detect.
From the RNS.....“ These agreements include framework Master Services Agreements with 2 of the world's largest suppliers of consumer products related to skincare.”
Definition.....A master service agreement, sometimes known as a framework agreement, is a contract reached between parties, in which the parties agree to most of the terms that will govern future transactions or future agreements. A master agreement permits the parties to quickly enact future transactions or agreements, negotiating only the points specific to the new transactions and relying on the provisions in the master agreement for common terms.
To me this is what stands out....momentum is well and truly building for DVRG. I bought more this morning.
Nice RNS! Another £400k revenue in just one quarter and a soft launch, it sounds like theres much more potential next year. Service agreements for 2 of the world’s largest skincare product companies and a full on launch next year, what’s not to like! Good way to announce it too, no hints and drop it like it’s hot, keeps people guessing as to what’s coming next.
It does seem to have become a traders share of late and just bounces between the low to high 20’s each week. It would be nice to see us leave that range and become popular with those who have a more long term view. I suppose it’s still early days though in the DVRg story.
A fair comment Gerard, and I wasn’t aware that any contract RNS has to be over 10% of revenue to be considered material. Without sounding disrespectful, the customers/clients may not read the RNS’s but shareholders and potential share holders do and you know how the AIM investors are, a lot of SP’s react to news or lack of news . I’m quite content to sit as I’m investing for the long term but a lot of AIM investors don’t have the same outlook. If only we could get out of AIM as this seems to be a recurring theme whenever the SP falls.....all in good time
I think we will be stuck in the mid 20’s until news. An update on phase 3 testing would be good. You know how AIM is, it doesn’t like waiting on news. Probably a bit of uncertainty in the markets with the whole Brexit thing this week. Even though are target markets are outside the UK.
Where is the 100million BT units figure coming from out of interest? I would have thought they will be made (or bought in if that’s what the plan is) in batches as and when contracts are signed? It will probably be small to start off with say a factory wants 1000 units a few thousand chips and a few scanners? Supply those, get paid for them, rinse and repeat as orders come in. Unless there is a big order from government/nhs/ cruise liners etc. It’s all guess work at this stage though.
From 16th November RNS
“As we progress towards commercialisation, PulMoBioMed's patented technology will enable a quick roll-out of our Microtox BT breath test once field trials have completed. We look forward to reporting the results in due course."
Probably awaiting the results of phase 3 field tests and there probably has to be a signed contract before DVRG would put its name to anything as it would be market sensitive. Im content to wait though.
How can DVRG not be involved! Have a look at appendix 7.1 (Innovation and partnerships) the problems they highlighted are exactly what Microtox PD solves! GB has to be all over this like a rash, he’s usually well ahead of the game.
I think everyone expects the BT to fail and this is priced into the SP. if it turns out that it’s more reliable and accurate than the lateral flow tests we are off to the races. I really hope this is the case and we get that magic RNS in the next few weeks. If not we’ll no biggie, as said it’s the water detection and labskin that will be a bigger player, the BT being a success would be the cherry on top.
Trouble buying this morning, had to wait for ages to get another £500 worth. Could bet get the buy at 24p so had to settle for 25p. Ah well as I say anything 25p and under is my buy range
No such thing as bad publicity. As GB says now all his followers know about DVRG and yes thanks for the opportunity to lower my average further, getting into the low 30’s after today’s top up.
I say fair play to GB for putting TW back in his box. I would do the same....it’s an Irish thing ;-)
GB clearly doesn’t suffer fools gladly.
That should give a bit of confidence to anyone who’s having doubts about where DVRG are going in the future.
I think it’s quite simple. Anyone who isn’t happy here should move on, I really don’t know why someone would waste time and energy on something they have no confidence in. I’m all for balanced discussion on the good and the bad (it’s isn’t all rosey here) but the moaning is starting to grind. I also got slightly burnt on the news of the BT spike but I didn’t go in too heavy and my average is on the 30’s(having averaged down) so I’m not sitting on a massive loss.
The only reason I would feel the need to sell up now is if the company was going bust and I highly doubt that will happen, it’s growing rapidly (recruitment of staff, large increases in revenue) and I believe DVRG is only getting traction now so lots more to come in the future. I’ve sold out before in the past when a share is going thorough a bad patch and lived to regret it as it recovers and goes higher after x amount of time. If DVRG was falling off a cliff I would sell now but it ain’t so I’m sitting tight and seeing what next year brings. The SP will react to the growth in good time.